|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:NVL-LARS2 (FusionGDB2 ID:60794) |
Fusion Gene Summary for NVL-LARS2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: NVL-LARS2 | Fusion gene ID: 60794 | Hgene | Tgene | Gene symbol | NVL | LARS2 | Gene ID | 4931 | 23395 |
Gene name | nuclear VCP like | leucyl-tRNA synthetase 2, mitochondrial | |
Synonyms | NVL2 | HLASA|LEURS|PRLTS4|mtLeuRS | |
Cytomap | 1q42.11 | 3p21.31 | |
Type of gene | protein-coding | protein-coding | |
Description | nuclear valosin-containing protein-likeNVLp | probable leucine--tRNA ligase, mitochondrialleucine tRNA ligase 2, mitochondrialleucine tRNA ligase 2, mitocondrialleucine translaseprobable leucyl-tRNA synthetase, mitochondrial | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | Q15031 | |
Ensembl transtripts involved in fusion gene | ENST00000391875, ENST00000281701, ENST00000469075, ENST00000482491, ENST00000340871, ENST00000361463, ENST00000468673, | ENST00000265537, ENST00000415258, ENST00000414984, ENST00000467936, | |
Fusion gene scores | * DoF score | 11 X 11 X 8=968 | 5 X 7 X 6=210 |
# samples | 12 | 7 | |
** MAII score | log2(12/968*10)=-3.01197264166608 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/210*10)=-1.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: NVL [Title/Abstract] AND LARS2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | NVL(224492736)-LARS2(45583321), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | NVL-LARS2 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. NVL-LARS2 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | NVL | GO:0006364 | rRNA processing | 29107693 |
Hgene | NVL | GO:0032092 | positive regulation of protein binding | 29107693 |
Hgene | NVL | GO:0042273 | ribosomal large subunit biogenesis | 26166824 |
Hgene | NVL | GO:1904749 | regulation of protein localization to nucleolus | 29107693 |
Tgene | LARS2 | GO:0006429 | leucyl-tRNA aminoacylation | 10684970 |
Fusion gene breakpoints across NVL (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across LARS2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BLCA | TCGA-BL-A0C8-01A | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
Top |
Fusion Gene ORF analysis for NVL-LARS2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000391875 | ENST00000265537 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
In-frame | ENST00000391875 | ENST00000415258 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
In-frame | ENST00000391875 | ENST00000414984 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
5CDS-intron | ENST00000391875 | ENST00000467936 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
In-frame | ENST00000281701 | ENST00000265537 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
In-frame | ENST00000281701 | ENST00000415258 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
In-frame | ENST00000281701 | ENST00000414984 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
5CDS-intron | ENST00000281701 | ENST00000467936 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
In-frame | ENST00000469075 | ENST00000265537 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
In-frame | ENST00000469075 | ENST00000415258 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
In-frame | ENST00000469075 | ENST00000414984 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
5CDS-intron | ENST00000469075 | ENST00000467936 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
5UTR-3CDS | ENST00000482491 | ENST00000265537 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
5UTR-3CDS | ENST00000482491 | ENST00000415258 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
5UTR-3CDS | ENST00000482491 | ENST00000414984 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
5UTR-intron | ENST00000482491 | ENST00000467936 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
Frame-shift | ENST00000340871 | ENST00000265537 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
Frame-shift | ENST00000340871 | ENST00000415258 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
Frame-shift | ENST00000340871 | ENST00000414984 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
5CDS-intron | ENST00000340871 | ENST00000467936 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
Frame-shift | ENST00000361463 | ENST00000265537 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
Frame-shift | ENST00000361463 | ENST00000415258 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
Frame-shift | ENST00000361463 | ENST00000414984 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
5CDS-intron | ENST00000361463 | ENST00000467936 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
intron-3CDS | ENST00000468673 | ENST00000265537 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
intron-3CDS | ENST00000468673 | ENST00000415258 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
intron-3CDS | ENST00000468673 | ENST00000414984 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
intron-intron | ENST00000468673 | ENST00000467936 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000391875 | NVL | chr1 | 224492736 | - | ENST00000265537 | LARS2 | chr3 | 45583321 | + | 2332 | 717 | 56 | 1024 | 322 |
ENST00000391875 | NVL | chr1 | 224492736 | - | ENST00000415258 | LARS2 | chr3 | 45583321 | + | 2916 | 717 | 56 | 1024 | 322 |
ENST00000391875 | NVL | chr1 | 224492736 | - | ENST00000414984 | LARS2 | chr3 | 45583321 | + | 1104 | 717 | 56 | 1024 | 322 |
ENST00000281701 | NVL | chr1 | 224492736 | - | ENST00000265537 | LARS2 | chr3 | 45583321 | + | 2623 | 1008 | 224 | 1315 | 363 |
ENST00000281701 | NVL | chr1 | 224492736 | - | ENST00000415258 | LARS2 | chr3 | 45583321 | + | 3207 | 1008 | 224 | 1315 | 363 |
ENST00000281701 | NVL | chr1 | 224492736 | - | ENST00000414984 | LARS2 | chr3 | 45583321 | + | 1395 | 1008 | 224 | 1315 | 363 |
ENST00000469075 | NVL | chr1 | 224492736 | - | ENST00000265537 | LARS2 | chr3 | 45583321 | + | 2101 | 486 | 11 | 793 | 260 |
ENST00000469075 | NVL | chr1 | 224492736 | - | ENST00000415258 | LARS2 | chr3 | 45583321 | + | 2685 | 486 | 11 | 793 | 260 |
ENST00000469075 | NVL | chr1 | 224492736 | - | ENST00000414984 | LARS2 | chr3 | 45583321 | + | 873 | 486 | 11 | 793 | 260 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000391875 | ENST00000265537 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + | 0.003183665 | 0.99681634 |
ENST00000391875 | ENST00000415258 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + | 0.001598004 | 0.99840206 |
ENST00000391875 | ENST00000414984 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + | 0.003306062 | 0.99669397 |
ENST00000281701 | ENST00000265537 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + | 0.002061691 | 0.99793833 |
ENST00000281701 | ENST00000415258 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + | 0.0012723 | 0.99872774 |
ENST00000281701 | ENST00000414984 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + | 0.002172591 | 0.99782735 |
ENST00000469075 | ENST00000265537 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + | 0.001623133 | 0.99837685 |
ENST00000469075 | ENST00000415258 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + | 0.000959021 | 0.9990409 |
ENST00000469075 | ENST00000414984 | NVL | chr1 | 224492736 | - | LARS2 | chr3 | 45583321 | + | 0.001458057 | 0.99854195 |
Top |
Fusion Genomic Features for NVL-LARS2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
NVL | chr1 | 224492735 | - | LARS2 | chr3 | 45583320 | + | 9.24E-07 | 0.99999905 |
NVL | chr1 | 224492735 | - | LARS2 | chr3 | 45583320 | + | 9.24E-07 | 0.99999905 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for NVL-LARS2 |
Go to FGviewer for the breakpoints of chr1:224492736-chr3:45583321 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | LARS2 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000281701 | - | 7 | 23 | 218_232 | 249.33333333333334 | 857.0 | Motif | Nuclear localization signal |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000281701 | - | 7 | 23 | 49_52 | 249.33333333333334 | 857.0 | Motif | Nucleolar localization signal |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000281701 | - | 7 | 23 | 85_88 | 249.33333333333334 | 857.0 | Motif | Nuclear localization signal |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000391875 | - | 6 | 22 | 49_52 | 143.33333333333334 | 751.0 | Motif | Nucleolar localization signal |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000391875 | - | 6 | 22 | 85_88 | 143.33333333333334 | 751.0 | Motif | Nuclear localization signal |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000469075 | - | 6 | 22 | 49_52 | 158.33333333333334 | 766.0 | Motif | Nucleolar localization signal |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000469075 | - | 6 | 22 | 85_88 | 158.33333333333334 | 766.0 | Motif | Nuclear localization signal |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000340871 | - | 4 | 21 | 218_232 | 33.333333333333336 | 668.0 | Motif | Nuclear localization signal |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000340871 | - | 4 | 21 | 49_52 | 33.333333333333336 | 668.0 | Motif | Nucleolar localization signal |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000340871 | - | 4 | 21 | 85_88 | 33.333333333333336 | 668.0 | Motif | Nuclear localization signal |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000391875 | - | 6 | 22 | 218_232 | 143.33333333333334 | 751.0 | Motif | Nuclear localization signal |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000469075 | - | 6 | 22 | 218_232 | 158.33333333333334 | 766.0 | Motif | Nuclear localization signal |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000281701 | - | 7 | 23 | 305_312 | 249.33333333333334 | 857.0 | Nucleotide binding | ATP |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000281701 | - | 7 | 23 | 622_629 | 249.33333333333334 | 857.0 | Nucleotide binding | ATP |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000340871 | - | 4 | 21 | 305_312 | 33.333333333333336 | 668.0 | Nucleotide binding | ATP |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000340871 | - | 4 | 21 | 622_629 | 33.333333333333336 | 668.0 | Nucleotide binding | ATP |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000391875 | - | 6 | 22 | 305_312 | 143.33333333333334 | 751.0 | Nucleotide binding | ATP |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000391875 | - | 6 | 22 | 622_629 | 143.33333333333334 | 751.0 | Nucleotide binding | ATP |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000469075 | - | 6 | 22 | 305_312 | 158.33333333333334 | 766.0 | Nucleotide binding | ATP |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000469075 | - | 6 | 22 | 622_629 | 158.33333333333334 | 766.0 | Nucleotide binding | ATP |
Tgene | LARS2 | chr1:224492736 | chr3:45583321 | ENST00000265537 | 19 | 22 | 639_643 | 801.3333333333334 | 904.0 | Motif | Note='KMSKS' region | |
Tgene | LARS2 | chr1:224492736 | chr3:45583321 | ENST00000265537 | 19 | 22 | 92_102 | 801.3333333333334 | 904.0 | Motif | Note='HIGH' region | |
Tgene | LARS2 | chr1:224492736 | chr3:45583321 | ENST00000415258 | 18 | 21 | 639_643 | 801.3333333333334 | 904.0 | Motif | Note='KMSKS' region | |
Tgene | LARS2 | chr1:224492736 | chr3:45583321 | ENST00000415258 | 18 | 21 | 92_102 | 801.3333333333334 | 904.0 | Motif | Note='HIGH' region |
Top |
Fusion Gene Sequence for NVL-LARS2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000391875_ENST00000265537_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(transcript)=2332nt_BP=717nt CTAGGAGCTGGCGGTCCGAGCTGTGGCTTGGAAGACCGACGCGATGAAGCCCAGACCTGCAGGGTTCGTGGATAATAAACTCAAGCAGCG AGTCATCCAGTATAGACTATGGTCGAAGAAAAAGAAATGCTTTTAGGATTCAGGTAGAAAAAGTATTTAGCATAATTAGTAGTGAGAAGG AACTTAAGAATTTAACAGAATTAGAAGATGAACATTTGGCAAAAAGGGCAAGACAAGGTGAAGAGGATAATGAGTATACTGAAAGCTATT CTGATGATGATTCAAGTATGGAAGACTACCCAGATCCACAGTCAGCAAATCACATGAACAGTTCCCTGCTGTCTTTATATCGGAAAGGAA ATCCTGATTCTGTTTCAAATACTCCTGAGATGGAGCAAAGAGAAACCACCTCTTCAACACCACGGATAAGTTCCAAAACAGGCTCCATTC CCTTGAAGACCCCTGCCAAAGATTCTGAAGGAGGATGGTTTATTGACAAAACCCCAAGTGTAAAGAAAGACAGTTTTTTCTTGGACCTGT CATGTGAGAAAAGTAATCCTAAGAAGCCAATAACTGAGATACAGGATTCAAAAGATTCTTCTCTTTTGGAGAGTGATATGAAACGGAAAG GCAAGCTAAAGAATAAAGGAAGCAAAAGGAAGAAAGAAGATCTTCAGGAAGTAGATGGAGAAATTGAAGCTGTCCTGCAAAAGAAAGGCC TGGCGCTGGTGCCGAGGAAGCTCTGTGCCCACTACACTTGGGATGCCAGTGTGCTGCTCCAGGCATGGCCTGCTGTGGACCCGGAGTTCC TGCAGCAGCCTGAGGTTGTCCAGATGGCAGTTCTGATCAACAATAAAGCTTGTGGCAAAATTCCTGTGCCCCAACAAGTTGCCCGGGACC AGGACAAAGTCCACGAATTTGTTCTTCAAAGCGAGCTGGGTGTCAGGCTTTTGCAAGGACGAAGCATCAAGAAGTCCTTCCTTTCCCCGA GAACTGCCCTCATCAACTTCCTGGTGCAAGATTGACAGCCAGGAGGCTGCAGCTACCACGAGGGCCTCTGAGGAACCTCCTTCCAGGCCT GGGATGAGGGGGCGATGTCTGCTGGCCCAGGGGAAGGGAAAAGACAAATGTCTTGACTGTTGACCTCGGTCCTGTGGCAGACTGCAGTCA ACAGTGTGCCTCTGTAGTGTGGCCTGGTGCTGGGGTGAAGGTGAGCTGGGCAAAGGAGAAATATGAGCTACTGAGGAGGGGGTTGGACAT CCTGCCCCTCACCCCCCACCCACACTGCAGGTAGAGGAGGCCATCTGATCCCATGGGAAGCCATCAGAGACACTGCTGGTGGGAGCAGGA AGGAGCAGTGCCCCTCGAGCAGCCAGGAAGCCTGCGGATCTGGGAAATGGCTCTGCCTTAGGCACTTCTCGGGAATTTGAGGCCAGCCTG AGGAACTGCAGGACTCAGGTGCAATGTGCCAGCCACTTGGAACTGCTAACTGAGCCTCCAGATGGTAGTGAATGGTCTCTTTGCCTTCAG GCTGGATGAGGAAGTCATTTAGGAAATGTTCAAATAACCAATATGTGGAAATGGACACAGGGATCTTCTGAAGTTGCTTTGAATCAAAAG GCAGGCAGTGCTGGTTCCTCTGCCTGTGTCCCCACCACTCCCCAGCTCTGTCATGCAGGCCTGTCCTCCCCAACCCCAGCTGGATGTGCC TCCCAGGCCTGCTGTGGTTCTGACACACAGGATCCCAGGCAAGGCACCACTTCCTCACATGAATGAGGAGCAGCAAGTCATAACCACTCC CTTGGGTATACAATTTGCTGTGTAGTGAAGTGGAACCAGGCTCAGGCTGCTGGTCCCAACCTCAGAGCCCCACCGCAGCCCAGTAGGGAT GCAGCACGCCCCAGAGGGCTCATGTGGGCCCCAGATGGCAATGCCACCATTGTTGATGTGACTCCAGAGCCAGTTATTAGGAAGAGCAAG CTCACCACAGAGGAGTGGAACTGAGGCCCCCCAGATGTTGCCTCCGGTGTCCAAGCCACAGCGGTCTGGCTGTTGGGAAGATGGCCAGGA ATGGACTCATACCATTGGCACATTAGGCTAATCCTGGTTTTATGTGAAGTCAGCAATTAAGTGTTCCCACTAGAACTGACCTAAGCCACT GATTAATATTTAATGAGGGAAGGTAGGGGAGAATCTAGCCATTTTATAATGCCAGAAATCTATATATGTTATCTGATGCCATTTTTCTGA >In-frame_ENST00000391875_ENST00000265537_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(amino acids)=322AA_start in transcript=56_stop in transcript=1024 MQGSWIINSSSESSSIDYGRRKRNAFRIQVEKVFSIISSEKELKNLTELEDEHLAKRARQGEEDNEYTESYSDDDSSMEDYPDPQSANHM NSSLLSLYRKGNPDSVSNTPEMEQRETTSSTPRISSKTGSIPLKTPAKDSEGGWFIDKTPSVKKDSFFLDLSCEKSNPKKPITEIQDSKD SSLLESDMKRKGKLKNKGSKRKKEDLQEVDGEIEAVLQKKGLALVPRKLCAHYTWDASVLLQAWPAVDPEFLQQPEVVQMAVLINNKACG -------------------------------------------------------------- >In-frame_ENST00000391875_ENST00000415258_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(transcript)=2916nt_BP=717nt CTAGGAGCTGGCGGTCCGAGCTGTGGCTTGGAAGACCGACGCGATGAAGCCCAGACCTGCAGGGTTCGTGGATAATAAACTCAAGCAGCG AGTCATCCAGTATAGACTATGGTCGAAGAAAAAGAAATGCTTTTAGGATTCAGGTAGAAAAAGTATTTAGCATAATTAGTAGTGAGAAGG AACTTAAGAATTTAACAGAATTAGAAGATGAACATTTGGCAAAAAGGGCAAGACAAGGTGAAGAGGATAATGAGTATACTGAAAGCTATT CTGATGATGATTCAAGTATGGAAGACTACCCAGATCCACAGTCAGCAAATCACATGAACAGTTCCCTGCTGTCTTTATATCGGAAAGGAA ATCCTGATTCTGTTTCAAATACTCCTGAGATGGAGCAAAGAGAAACCACCTCTTCAACACCACGGATAAGTTCCAAAACAGGCTCCATTC CCTTGAAGACCCCTGCCAAAGATTCTGAAGGAGGATGGTTTATTGACAAAACCCCAAGTGTAAAGAAAGACAGTTTTTTCTTGGACCTGT CATGTGAGAAAAGTAATCCTAAGAAGCCAATAACTGAGATACAGGATTCAAAAGATTCTTCTCTTTTGGAGAGTGATATGAAACGGAAAG GCAAGCTAAAGAATAAAGGAAGCAAAAGGAAGAAAGAAGATCTTCAGGAAGTAGATGGAGAAATTGAAGCTGTCCTGCAAAAGAAAGGCC TGGCGCTGGTGCCGAGGAAGCTCTGTGCCCACTACACTTGGGATGCCAGTGTGCTGCTCCAGGCATGGCCTGCTGTGGACCCGGAGTTCC TGCAGCAGCCTGAGGTTGTCCAGATGGCAGTTCTGATCAACAATAAAGCTTGTGGCAAAATTCCTGTGCCCCAACAAGTTGCCCGGGACC AGGACAAAGTCCACGAATTTGTTCTTCAAAGCGAGCTGGGTGTCAGGCTTTTGCAAGGACGAAGCATCAAGAAGTCCTTCCTTTCCCCGA GAACTGCCCTCATCAACTTCCTGGTGCAAGATTGACAGCCAGGAGGCTGCAGCTACCACGAGGGCCTCTGAGGAACCTCCTTCCAGGCCT GGGATGAGGGGGCGATGTCTGCTGGCCCAGGGGAAGGGAAAAGACAAATGTCTTGACTGTTGACCTCGGTCCTGTGGCAGACTGCAGTCA ACAGTGTGCCTCTGTAGTGTGGCCTGGTGCTGGGGTGAAGGTGAGCTGGGCAAAGGAGAAATATGAGCTACTGAGGAGGGGGTTGGACAT CCTGCCCCTCACCCCCCACCCACACTGCAGGTAGAGGAGGCCATCTGATCCCATGGGAAGCCATCAGAGACACTGCTGGTGGGAGCAGGA AGGAGCAGTGCCCCTCGAGCAGCCAGGAAGCCTGCGGATCTGGGAAATGGCTCTGCCTTAGGCACTTCTCGGGAATTTGAGGCCAGCCTG AGGAACTGCAGGACTCAGGTGCAATGTGCCAGCCACTTGGAACTGCTAACTGAGCCTCCAGATGGTAGTGAATGGTCTCTTTGCCTTCAG GCTGGATGAGGAAGTCATTTAGGAAATGTTCAAATAACCAATATGTGGAAATGGACACAGGGATCTTCTGAAGTTGCTTTGAATCAAAAG GCAGGCAGTGCTGGTTCCTCTGCCTGTGTCCCCACCACTCCCCAGCTCTGTCATGCAGGCCTGTCCTCCCCAACCCCAGCTGGATGTGCC TCCCAGGCCTGCTGTGGTTCTGACACACAGGATCCCAGGCAAGGCACCACTTCCTCACATGAATGAGGAGCAGCAAGTCATAACCACTCC CTTGGGTATACAATTTGCTGTGTAGTGAAGTGGAACCAGGCTCAGGCTGCTGGTCCCAACCTCAGAGCCCCACCGCAGCCCAGTAGGGAT GCAGCACGCCCCAGAGGGCTCATGTGGGCCCCAGATGGCAATGCCACCATTGTTGATGTGACTCCAGAGCCAGTTATTAGGAAGAGCAAG CTCACCACAGAGGAGTGGAACTGAGGCCCCCCAGATGTTGCCTCCGGTGTCCAAGCCACAGCGGTCTGGCTGTTGGGAAGATGGCCAGGA ATGGACTCATACCATTGGCACATTAGGCTAATCCTGGTTTTATGTGAAGTCAGCAATTAAGTGTTCCCACTAGAACTGACCTAAGCCACT GATTAATATTTAATGAGGGAAGGTAGGGGAGAATCTAGCCATTTTATAATGCCAGAAATCTATATATGTTATCTGATGCCATTTTTCTGA AGTAGCCTCACATGTGGTCCCCCTGCAGTTCAGCAGTTAACAGATGACTTTTTTAGTGTAATAAAATGTTTATCATCTATGACTTCAGGA CATATGTGTGATCCTGGAATACACCATATTCCAATTTCAGAGTTAATTACAAACAGATTGAGGTATTCCATCATCATCGGAAGCATTGGC TGTGTGTCTGACTCCACATGGAATGCTATAAAGTGGGATACATGTGGTTCTTCTTGTTCCAGAACTTACAGTCCATGGTAGACAACACTG ATACAGGCAAACTAGCAACAGCAATTAAGTCACTGGTTCTCAGACTTAATACTCTGCCTGGTCCTCATGCCCAGATATTCCAATTTAATT GGTCCATGGTGTGGCTTGAACACCAGGAATCTTTAAAACTCCACAAGTGATTCTAATGGGCAGCAAAGTTTGAGAATCACTGGACACATT GATGCACTTGAGCCATCATTTCTATCTAGTTCTTCCTCTTCCTAATCTTCAGGTTAGCGGGGATAAGTTTGGTCCAGGACCAAGAGTTGG ACCAAAAGGGAAGACAGGGGCCAGAAGTCTAGAGTGCTAGAGCCGACTTGAATGTACTCAGTCTCATTGCACATGGCAGTGAATATGGAT >In-frame_ENST00000391875_ENST00000415258_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(amino acids)=322AA_start in transcript=56_stop in transcript=1024 MQGSWIINSSSESSSIDYGRRKRNAFRIQVEKVFSIISSEKELKNLTELEDEHLAKRARQGEEDNEYTESYSDDDSSMEDYPDPQSANHM NSSLLSLYRKGNPDSVSNTPEMEQRETTSSTPRISSKTGSIPLKTPAKDSEGGWFIDKTPSVKKDSFFLDLSCEKSNPKKPITEIQDSKD SSLLESDMKRKGKLKNKGSKRKKEDLQEVDGEIEAVLQKKGLALVPRKLCAHYTWDASVLLQAWPAVDPEFLQQPEVVQMAVLINNKACG -------------------------------------------------------------- >In-frame_ENST00000391875_ENST00000414984_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(transcript)=1104nt_BP=717nt CTAGGAGCTGGCGGTCCGAGCTGTGGCTTGGAAGACCGACGCGATGAAGCCCAGACCTGCAGGGTTCGTGGATAATAAACTCAAGCAGCG AGTCATCCAGTATAGACTATGGTCGAAGAAAAAGAAATGCTTTTAGGATTCAGGTAGAAAAAGTATTTAGCATAATTAGTAGTGAGAAGG AACTTAAGAATTTAACAGAATTAGAAGATGAACATTTGGCAAAAAGGGCAAGACAAGGTGAAGAGGATAATGAGTATACTGAAAGCTATT CTGATGATGATTCAAGTATGGAAGACTACCCAGATCCACAGTCAGCAAATCACATGAACAGTTCCCTGCTGTCTTTATATCGGAAAGGAA ATCCTGATTCTGTTTCAAATACTCCTGAGATGGAGCAAAGAGAAACCACCTCTTCAACACCACGGATAAGTTCCAAAACAGGCTCCATTC CCTTGAAGACCCCTGCCAAAGATTCTGAAGGAGGATGGTTTATTGACAAAACCCCAAGTGTAAAGAAAGACAGTTTTTTCTTGGACCTGT CATGTGAGAAAAGTAATCCTAAGAAGCCAATAACTGAGATACAGGATTCAAAAGATTCTTCTCTTTTGGAGAGTGATATGAAACGGAAAG GCAAGCTAAAGAATAAAGGAAGCAAAAGGAAGAAAGAAGATCTTCAGGAAGTAGATGGAGAAATTGAAGCTGTCCTGCAAAAGAAAGGCC TGGCGCTGGTGCCGAGGAAGCTCTGTGCCCACTACACTTGGGATGCCAGTGTGCTGCTCCAGGCATGGCCTGCTGTGGACCCGGAGTTCC TGCAGCAGCCTGAGGTTGTCCAGATGGCAGTTCTGATCAACAATAAAGCTTGTGGCAAAATTCCTGTGCCCCAACAAGTTGCCCGGGACC AGGACAAAGTCCACGAATTTGTTCTTCAAAGCGAGCTGGGTGTCAGGCTTTTGCAAGGACGAAGCATCAAGAAGTCCTTCCTTTCCCCGA GAACTGCCCTCATCAACTTCCTGGTGCAAGATTGACAGCCAGGAGGCTGCAGCTACCACGAGGGCCTCTGAGGAACCTCCTTCCAGGCCT >In-frame_ENST00000391875_ENST00000414984_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(amino acids)=322AA_start in transcript=56_stop in transcript=1024 MQGSWIINSSSESSSIDYGRRKRNAFRIQVEKVFSIISSEKELKNLTELEDEHLAKRARQGEEDNEYTESYSDDDSSMEDYPDPQSANHM NSSLLSLYRKGNPDSVSNTPEMEQRETTSSTPRISSKTGSIPLKTPAKDSEGGWFIDKTPSVKKDSFFLDLSCEKSNPKKPITEIQDSKD SSLLESDMKRKGKLKNKGSKRKKEDLQEVDGEIEAVLQKKGLALVPRKLCAHYTWDASVLLQAWPAVDPEFLQQPEVVQMAVLINNKACG -------------------------------------------------------------- >In-frame_ENST00000281701_ENST00000265537_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(transcript)=2623nt_BP=1008nt AATCTTCCAGGGTCCACTGGGCAGGCCTGCAAAATAAGGCCCCTAGAAACTCCCTGAGGTTTTCAAGTCTTCTCCCTCTCCTCGGAATTT TTTCCCCTTCATTCGCATTACTTTTATTCTGACGGAAACGGCGCGGGCTAGGCCCCAGGAGGGGCGCATTTCAGGTGCAACTGGCCCGGC GATCGCGGCGGGCAACCCCTACGAGGCCCCCGGTTGACTAGGAGCTGGCGGTCCGAGCTGTGGCTTGGAAGACCGACGCGATGAAGCCCA GACCTGCAGGGTTCGTGGATAATAAACTCAAGCAGCGAGTCATCCAGTACCTTACCAGTAACAAATGTGGCAAATATGTGGACATTGGAG TCTTAGCGTCTGATTTACAAAGAGTGTACAGTATAGACTATGGTCGAAGAAAAAGAAATGCTTTTAGGATTCAGGTAGAAAAAGTATTTA GCATAATTAGTAGTGAGAAGGAACTTAAGAATTTAACAGAATTAGAAGATGAACATTTGGCAAAAAGGGCAAGACAAGGTGAAGAGGATA ATGAGTATACTGAAAGCTATTCTGATGATGATTCAAGTATGGAAGACTACCCAGATCCACAGTCAGCAAATCACATGAACAGTTCCCTGC TGTCTTTATATCGGAAAGGAAATCCTGATTCTGTTTCAAATACTCCTGAGATGGAGCAAAGAGAAACCACCTCTTCAACACCACGGATAA GTTCCAAAACAGGCTCCATTCCCTTGAAGACCCCTGCCAAAGATTCTGAAGGAGGATGGTTTATTGACAAAACCCCAAGTGTAAAGAAAG ACAGTTTTTTCTTGGACCTGTCATGTGAGAAAAGTAATCCTAAGAAGCCAATAACTGAGATACAGGATTCAAAAGATTCTTCTCTTTTGG AGAGTGATATGAAACGGAAAGGCAAGCTAAAGAATAAAGGAAGCAAAAGGAAGAAAGAAGATCTTCAGGAAGTAGATGGAGAAATTGAAG CTGTCCTGCAAAAGAAAGGCCTGGCGCTGGTGCCGAGGAAGCTCTGTGCCCACTACACTTGGGATGCCAGTGTGCTGCTCCAGGCATGGC CTGCTGTGGACCCGGAGTTCCTGCAGCAGCCTGAGGTTGTCCAGATGGCAGTTCTGATCAACAATAAAGCTTGTGGCAAAATTCCTGTGC CCCAACAAGTTGCCCGGGACCAGGACAAAGTCCACGAATTTGTTCTTCAAAGCGAGCTGGGTGTCAGGCTTTTGCAAGGACGAAGCATCA AGAAGTCCTTCCTTTCCCCGAGAACTGCCCTCATCAACTTCCTGGTGCAAGATTGACAGCCAGGAGGCTGCAGCTACCACGAGGGCCTCT GAGGAACCTCCTTCCAGGCCTGGGATGAGGGGGCGATGTCTGCTGGCCCAGGGGAAGGGAAAAGACAAATGTCTTGACTGTTGACCTCGG TCCTGTGGCAGACTGCAGTCAACAGTGTGCCTCTGTAGTGTGGCCTGGTGCTGGGGTGAAGGTGAGCTGGGCAAAGGAGAAATATGAGCT ACTGAGGAGGGGGTTGGACATCCTGCCCCTCACCCCCCACCCACACTGCAGGTAGAGGAGGCCATCTGATCCCATGGGAAGCCATCAGAG ACACTGCTGGTGGGAGCAGGAAGGAGCAGTGCCCCTCGAGCAGCCAGGAAGCCTGCGGATCTGGGAAATGGCTCTGCCTTAGGCACTTCT CGGGAATTTGAGGCCAGCCTGAGGAACTGCAGGACTCAGGTGCAATGTGCCAGCCACTTGGAACTGCTAACTGAGCCTCCAGATGGTAGT GAATGGTCTCTTTGCCTTCAGGCTGGATGAGGAAGTCATTTAGGAAATGTTCAAATAACCAATATGTGGAAATGGACACAGGGATCTTCT GAAGTTGCTTTGAATCAAAAGGCAGGCAGTGCTGGTTCCTCTGCCTGTGTCCCCACCACTCCCCAGCTCTGTCATGCAGGCCTGTCCTCC CCAACCCCAGCTGGATGTGCCTCCCAGGCCTGCTGTGGTTCTGACACACAGGATCCCAGGCAAGGCACCACTTCCTCACATGAATGAGGA GCAGCAAGTCATAACCACTCCCTTGGGTATACAATTTGCTGTGTAGTGAAGTGGAACCAGGCTCAGGCTGCTGGTCCCAACCTCAGAGCC CCACCGCAGCCCAGTAGGGATGCAGCACGCCCCAGAGGGCTCATGTGGGCCCCAGATGGCAATGCCACCATTGTTGATGTGACTCCAGAG CCAGTTATTAGGAAGAGCAAGCTCACCACAGAGGAGTGGAACTGAGGCCCCCCAGATGTTGCCTCCGGTGTCCAAGCCACAGCGGTCTGG CTGTTGGGAAGATGGCCAGGAATGGACTCATACCATTGGCACATTAGGCTAATCCTGGTTTTATGTGAAGTCAGCAATTAAGTGTTCCCA CTAGAACTGACCTAAGCCACTGATTAATATTTAATGAGGGAAGGTAGGGGAGAATCTAGCCATTTTATAATGCCAGAAATCTATATATGT TATCTGATGCCATTTTTCTGAAGTAGCCTCACATGTGGTCCCCCTGCAGTTCAGCAGTTAACAGATGACTTTTTTAGTGTAATAAAATGT >In-frame_ENST00000281701_ENST00000265537_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(amino acids)=363AA_start in transcript=224_stop in transcript=1315 MAVRAVAWKTDAMKPRPAGFVDNKLKQRVIQYLTSNKCGKYVDIGVLASDLQRVYSIDYGRRKRNAFRIQVEKVFSIISSEKELKNLTEL EDEHLAKRARQGEEDNEYTESYSDDDSSMEDYPDPQSANHMNSSLLSLYRKGNPDSVSNTPEMEQRETTSSTPRISSKTGSIPLKTPAKD SEGGWFIDKTPSVKKDSFFLDLSCEKSNPKKPITEIQDSKDSSLLESDMKRKGKLKNKGSKRKKEDLQEVDGEIEAVLQKKGLALVPRKL CAHYTWDASVLLQAWPAVDPEFLQQPEVVQMAVLINNKACGKIPVPQQVARDQDKVHEFVLQSELGVRLLQGRSIKKSFLSPRTALINFL -------------------------------------------------------------- >In-frame_ENST00000281701_ENST00000415258_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(transcript)=3207nt_BP=1008nt AATCTTCCAGGGTCCACTGGGCAGGCCTGCAAAATAAGGCCCCTAGAAACTCCCTGAGGTTTTCAAGTCTTCTCCCTCTCCTCGGAATTT TTTCCCCTTCATTCGCATTACTTTTATTCTGACGGAAACGGCGCGGGCTAGGCCCCAGGAGGGGCGCATTTCAGGTGCAACTGGCCCGGC GATCGCGGCGGGCAACCCCTACGAGGCCCCCGGTTGACTAGGAGCTGGCGGTCCGAGCTGTGGCTTGGAAGACCGACGCGATGAAGCCCA GACCTGCAGGGTTCGTGGATAATAAACTCAAGCAGCGAGTCATCCAGTACCTTACCAGTAACAAATGTGGCAAATATGTGGACATTGGAG TCTTAGCGTCTGATTTACAAAGAGTGTACAGTATAGACTATGGTCGAAGAAAAAGAAATGCTTTTAGGATTCAGGTAGAAAAAGTATTTA GCATAATTAGTAGTGAGAAGGAACTTAAGAATTTAACAGAATTAGAAGATGAACATTTGGCAAAAAGGGCAAGACAAGGTGAAGAGGATA ATGAGTATACTGAAAGCTATTCTGATGATGATTCAAGTATGGAAGACTACCCAGATCCACAGTCAGCAAATCACATGAACAGTTCCCTGC TGTCTTTATATCGGAAAGGAAATCCTGATTCTGTTTCAAATACTCCTGAGATGGAGCAAAGAGAAACCACCTCTTCAACACCACGGATAA GTTCCAAAACAGGCTCCATTCCCTTGAAGACCCCTGCCAAAGATTCTGAAGGAGGATGGTTTATTGACAAAACCCCAAGTGTAAAGAAAG ACAGTTTTTTCTTGGACCTGTCATGTGAGAAAAGTAATCCTAAGAAGCCAATAACTGAGATACAGGATTCAAAAGATTCTTCTCTTTTGG AGAGTGATATGAAACGGAAAGGCAAGCTAAAGAATAAAGGAAGCAAAAGGAAGAAAGAAGATCTTCAGGAAGTAGATGGAGAAATTGAAG CTGTCCTGCAAAAGAAAGGCCTGGCGCTGGTGCCGAGGAAGCTCTGTGCCCACTACACTTGGGATGCCAGTGTGCTGCTCCAGGCATGGC CTGCTGTGGACCCGGAGTTCCTGCAGCAGCCTGAGGTTGTCCAGATGGCAGTTCTGATCAACAATAAAGCTTGTGGCAAAATTCCTGTGC CCCAACAAGTTGCCCGGGACCAGGACAAAGTCCACGAATTTGTTCTTCAAAGCGAGCTGGGTGTCAGGCTTTTGCAAGGACGAAGCATCA AGAAGTCCTTCCTTTCCCCGAGAACTGCCCTCATCAACTTCCTGGTGCAAGATTGACAGCCAGGAGGCTGCAGCTACCACGAGGGCCTCT GAGGAACCTCCTTCCAGGCCTGGGATGAGGGGGCGATGTCTGCTGGCCCAGGGGAAGGGAAAAGACAAATGTCTTGACTGTTGACCTCGG TCCTGTGGCAGACTGCAGTCAACAGTGTGCCTCTGTAGTGTGGCCTGGTGCTGGGGTGAAGGTGAGCTGGGCAAAGGAGAAATATGAGCT ACTGAGGAGGGGGTTGGACATCCTGCCCCTCACCCCCCACCCACACTGCAGGTAGAGGAGGCCATCTGATCCCATGGGAAGCCATCAGAG ACACTGCTGGTGGGAGCAGGAAGGAGCAGTGCCCCTCGAGCAGCCAGGAAGCCTGCGGATCTGGGAAATGGCTCTGCCTTAGGCACTTCT CGGGAATTTGAGGCCAGCCTGAGGAACTGCAGGACTCAGGTGCAATGTGCCAGCCACTTGGAACTGCTAACTGAGCCTCCAGATGGTAGT GAATGGTCTCTTTGCCTTCAGGCTGGATGAGGAAGTCATTTAGGAAATGTTCAAATAACCAATATGTGGAAATGGACACAGGGATCTTCT GAAGTTGCTTTGAATCAAAAGGCAGGCAGTGCTGGTTCCTCTGCCTGTGTCCCCACCACTCCCCAGCTCTGTCATGCAGGCCTGTCCTCC CCAACCCCAGCTGGATGTGCCTCCCAGGCCTGCTGTGGTTCTGACACACAGGATCCCAGGCAAGGCACCACTTCCTCACATGAATGAGGA GCAGCAAGTCATAACCACTCCCTTGGGTATACAATTTGCTGTGTAGTGAAGTGGAACCAGGCTCAGGCTGCTGGTCCCAACCTCAGAGCC CCACCGCAGCCCAGTAGGGATGCAGCACGCCCCAGAGGGCTCATGTGGGCCCCAGATGGCAATGCCACCATTGTTGATGTGACTCCAGAG CCAGTTATTAGGAAGAGCAAGCTCACCACAGAGGAGTGGAACTGAGGCCCCCCAGATGTTGCCTCCGGTGTCCAAGCCACAGCGGTCTGG CTGTTGGGAAGATGGCCAGGAATGGACTCATACCATTGGCACATTAGGCTAATCCTGGTTTTATGTGAAGTCAGCAATTAAGTGTTCCCA CTAGAACTGACCTAAGCCACTGATTAATATTTAATGAGGGAAGGTAGGGGAGAATCTAGCCATTTTATAATGCCAGAAATCTATATATGT TATCTGATGCCATTTTTCTGAAGTAGCCTCACATGTGGTCCCCCTGCAGTTCAGCAGTTAACAGATGACTTTTTTAGTGTAATAAAATGT TTATCATCTATGACTTCAGGACATATGTGTGATCCTGGAATACACCATATTCCAATTTCAGAGTTAATTACAAACAGATTGAGGTATTCC ATCATCATCGGAAGCATTGGCTGTGTGTCTGACTCCACATGGAATGCTATAAAGTGGGATACATGTGGTTCTTCTTGTTCCAGAACTTAC AGTCCATGGTAGACAACACTGATACAGGCAAACTAGCAACAGCAATTAAGTCACTGGTTCTCAGACTTAATACTCTGCCTGGTCCTCATG CCCAGATATTCCAATTTAATTGGTCCATGGTGTGGCTTGAACACCAGGAATCTTTAAAACTCCACAAGTGATTCTAATGGGCAGCAAAGT TTGAGAATCACTGGACACATTGATGCACTTGAGCCATCATTTCTATCTAGTTCTTCCTCTTCCTAATCTTCAGGTTAGCGGGGATAAGTT TGGTCCAGGACCAAGAGTTGGACCAAAAGGGAAGACAGGGGCCAGAAGTCTAGAGTGCTAGAGCCGACTTGAATGTACTCAGTCTCATTG >In-frame_ENST00000281701_ENST00000415258_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(amino acids)=363AA_start in transcript=224_stop in transcript=1315 MAVRAVAWKTDAMKPRPAGFVDNKLKQRVIQYLTSNKCGKYVDIGVLASDLQRVYSIDYGRRKRNAFRIQVEKVFSIISSEKELKNLTEL EDEHLAKRARQGEEDNEYTESYSDDDSSMEDYPDPQSANHMNSSLLSLYRKGNPDSVSNTPEMEQRETTSSTPRISSKTGSIPLKTPAKD SEGGWFIDKTPSVKKDSFFLDLSCEKSNPKKPITEIQDSKDSSLLESDMKRKGKLKNKGSKRKKEDLQEVDGEIEAVLQKKGLALVPRKL CAHYTWDASVLLQAWPAVDPEFLQQPEVVQMAVLINNKACGKIPVPQQVARDQDKVHEFVLQSELGVRLLQGRSIKKSFLSPRTALINFL -------------------------------------------------------------- >In-frame_ENST00000281701_ENST00000414984_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(transcript)=1395nt_BP=1008nt AATCTTCCAGGGTCCACTGGGCAGGCCTGCAAAATAAGGCCCCTAGAAACTCCCTGAGGTTTTCAAGTCTTCTCCCTCTCCTCGGAATTT TTTCCCCTTCATTCGCATTACTTTTATTCTGACGGAAACGGCGCGGGCTAGGCCCCAGGAGGGGCGCATTTCAGGTGCAACTGGCCCGGC GATCGCGGCGGGCAACCCCTACGAGGCCCCCGGTTGACTAGGAGCTGGCGGTCCGAGCTGTGGCTTGGAAGACCGACGCGATGAAGCCCA GACCTGCAGGGTTCGTGGATAATAAACTCAAGCAGCGAGTCATCCAGTACCTTACCAGTAACAAATGTGGCAAATATGTGGACATTGGAG TCTTAGCGTCTGATTTACAAAGAGTGTACAGTATAGACTATGGTCGAAGAAAAAGAAATGCTTTTAGGATTCAGGTAGAAAAAGTATTTA GCATAATTAGTAGTGAGAAGGAACTTAAGAATTTAACAGAATTAGAAGATGAACATTTGGCAAAAAGGGCAAGACAAGGTGAAGAGGATA ATGAGTATACTGAAAGCTATTCTGATGATGATTCAAGTATGGAAGACTACCCAGATCCACAGTCAGCAAATCACATGAACAGTTCCCTGC TGTCTTTATATCGGAAAGGAAATCCTGATTCTGTTTCAAATACTCCTGAGATGGAGCAAAGAGAAACCACCTCTTCAACACCACGGATAA GTTCCAAAACAGGCTCCATTCCCTTGAAGACCCCTGCCAAAGATTCTGAAGGAGGATGGTTTATTGACAAAACCCCAAGTGTAAAGAAAG ACAGTTTTTTCTTGGACCTGTCATGTGAGAAAAGTAATCCTAAGAAGCCAATAACTGAGATACAGGATTCAAAAGATTCTTCTCTTTTGG AGAGTGATATGAAACGGAAAGGCAAGCTAAAGAATAAAGGAAGCAAAAGGAAGAAAGAAGATCTTCAGGAAGTAGATGGAGAAATTGAAG CTGTCCTGCAAAAGAAAGGCCTGGCGCTGGTGCCGAGGAAGCTCTGTGCCCACTACACTTGGGATGCCAGTGTGCTGCTCCAGGCATGGC CTGCTGTGGACCCGGAGTTCCTGCAGCAGCCTGAGGTTGTCCAGATGGCAGTTCTGATCAACAATAAAGCTTGTGGCAAAATTCCTGTGC CCCAACAAGTTGCCCGGGACCAGGACAAAGTCCACGAATTTGTTCTTCAAAGCGAGCTGGGTGTCAGGCTTTTGCAAGGACGAAGCATCA AGAAGTCCTTCCTTTCCCCGAGAACTGCCCTCATCAACTTCCTGGTGCAAGATTGACAGCCAGGAGGCTGCAGCTACCACGAGGGCCTCT >In-frame_ENST00000281701_ENST00000414984_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(amino acids)=363AA_start in transcript=224_stop in transcript=1315 MAVRAVAWKTDAMKPRPAGFVDNKLKQRVIQYLTSNKCGKYVDIGVLASDLQRVYSIDYGRRKRNAFRIQVEKVFSIISSEKELKNLTEL EDEHLAKRARQGEEDNEYTESYSDDDSSMEDYPDPQSANHMNSSLLSLYRKGNPDSVSNTPEMEQRETTSSTPRISSKTGSIPLKTPAKD SEGGWFIDKTPSVKKDSFFLDLSCEKSNPKKPITEIQDSKDSSLLESDMKRKGKLKNKGSKRKKEDLQEVDGEIEAVLQKKGLALVPRKL CAHYTWDASVLLQAWPAVDPEFLQQPEVVQMAVLINNKACGKIPVPQQVARDQDKVHEFVLQSELGVRLLQGRSIKKSFLSPRTALINFL -------------------------------------------------------------- >In-frame_ENST00000469075_ENST00000265537_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(transcript)=2101nt_BP=486nt AGACCGACGCGATGAAGCCCAGACCTGCAGGGTTCGTGGATAATAAACTCAAGCAGCGAGTCATCCAGTACCTTACCAGTAACAAATGTG GCAAATATGTGGACATTGGAGTCTTAGCGTCTGATTTACAAAGAGTGTACAGTATAGACTATGGTCGAAGAAAAAGAAATGCTTTTAGGA TTCAGGTAGAAAAAGTATTTAGCATAATTAGTAGTGAGAAGGAACTTAAGAATTTAACAGAATTAGAAGATGAACATTTGGCAAAAAGGG CAAGACAAGGTGAAGAGGATAATGAGTATACTGAAAGCTATTCTGATGATGATTCAAGTATGGAAGACTACCCAGATCCACAGGATTCAA AAGATTCTTCTCTTTTGGAGAGTGATATGAAACGGAAAGGCAAGCTAAAGAATAAAGGAAGCAAAAGGAAGAAAGAAGATCTTCAGGAAG TAGATGGAGAAATTGAAGCTGTCCTGCAAAAGAAAGGCCTGGCGCTGGTGCCGAGGAAGCTCTGTGCCCACTACACTTGGGATGCCAGTG TGCTGCTCCAGGCATGGCCTGCTGTGGACCCGGAGTTCCTGCAGCAGCCTGAGGTTGTCCAGATGGCAGTTCTGATCAACAATAAAGCTT GTGGCAAAATTCCTGTGCCCCAACAAGTTGCCCGGGACCAGGACAAAGTCCACGAATTTGTTCTTCAAAGCGAGCTGGGTGTCAGGCTTT TGCAAGGACGAAGCATCAAGAAGTCCTTCCTTTCCCCGAGAACTGCCCTCATCAACTTCCTGGTGCAAGATTGACAGCCAGGAGGCTGCA GCTACCACGAGGGCCTCTGAGGAACCTCCTTCCAGGCCTGGGATGAGGGGGCGATGTCTGCTGGCCCAGGGGAAGGGAAAAGACAAATGT CTTGACTGTTGACCTCGGTCCTGTGGCAGACTGCAGTCAACAGTGTGCCTCTGTAGTGTGGCCTGGTGCTGGGGTGAAGGTGAGCTGGGC AAAGGAGAAATATGAGCTACTGAGGAGGGGGTTGGACATCCTGCCCCTCACCCCCCACCCACACTGCAGGTAGAGGAGGCCATCTGATCC CATGGGAAGCCATCAGAGACACTGCTGGTGGGAGCAGGAAGGAGCAGTGCCCCTCGAGCAGCCAGGAAGCCTGCGGATCTGGGAAATGGC TCTGCCTTAGGCACTTCTCGGGAATTTGAGGCCAGCCTGAGGAACTGCAGGACTCAGGTGCAATGTGCCAGCCACTTGGAACTGCTAACT GAGCCTCCAGATGGTAGTGAATGGTCTCTTTGCCTTCAGGCTGGATGAGGAAGTCATTTAGGAAATGTTCAAATAACCAATATGTGGAAA TGGACACAGGGATCTTCTGAAGTTGCTTTGAATCAAAAGGCAGGCAGTGCTGGTTCCTCTGCCTGTGTCCCCACCACTCCCCAGCTCTGT CATGCAGGCCTGTCCTCCCCAACCCCAGCTGGATGTGCCTCCCAGGCCTGCTGTGGTTCTGACACACAGGATCCCAGGCAAGGCACCACT TCCTCACATGAATGAGGAGCAGCAAGTCATAACCACTCCCTTGGGTATACAATTTGCTGTGTAGTGAAGTGGAACCAGGCTCAGGCTGCT GGTCCCAACCTCAGAGCCCCACCGCAGCCCAGTAGGGATGCAGCACGCCCCAGAGGGCTCATGTGGGCCCCAGATGGCAATGCCACCATT GTTGATGTGACTCCAGAGCCAGTTATTAGGAAGAGCAAGCTCACCACAGAGGAGTGGAACTGAGGCCCCCCAGATGTTGCCTCCGGTGTC CAAGCCACAGCGGTCTGGCTGTTGGGAAGATGGCCAGGAATGGACTCATACCATTGGCACATTAGGCTAATCCTGGTTTTATGTGAAGTC AGCAATTAAGTGTTCCCACTAGAACTGACCTAAGCCACTGATTAATATTTAATGAGGGAAGGTAGGGGAGAATCTAGCCATTTTATAATG CCAGAAATCTATATATGTTATCTGATGCCATTTTTCTGAAGTAGCCTCACATGTGGTCCCCCTGCAGTTCAGCAGTTAACAGATGACTTT >In-frame_ENST00000469075_ENST00000265537_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(amino acids)=260AA_start in transcript=11_stop in transcript=793 MKPRPAGFVDNKLKQRVIQYLTSNKCGKYVDIGVLASDLQRVYSIDYGRRKRNAFRIQVEKVFSIISSEKELKNLTELEDEHLAKRARQG EEDNEYTESYSDDDSSMEDYPDPQDSKDSSLLESDMKRKGKLKNKGSKRKKEDLQEVDGEIEAVLQKKGLALVPRKLCAHYTWDASVLLQ -------------------------------------------------------------- >In-frame_ENST00000469075_ENST00000415258_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(transcript)=2685nt_BP=486nt AGACCGACGCGATGAAGCCCAGACCTGCAGGGTTCGTGGATAATAAACTCAAGCAGCGAGTCATCCAGTACCTTACCAGTAACAAATGTG GCAAATATGTGGACATTGGAGTCTTAGCGTCTGATTTACAAAGAGTGTACAGTATAGACTATGGTCGAAGAAAAAGAAATGCTTTTAGGA TTCAGGTAGAAAAAGTATTTAGCATAATTAGTAGTGAGAAGGAACTTAAGAATTTAACAGAATTAGAAGATGAACATTTGGCAAAAAGGG CAAGACAAGGTGAAGAGGATAATGAGTATACTGAAAGCTATTCTGATGATGATTCAAGTATGGAAGACTACCCAGATCCACAGGATTCAA AAGATTCTTCTCTTTTGGAGAGTGATATGAAACGGAAAGGCAAGCTAAAGAATAAAGGAAGCAAAAGGAAGAAAGAAGATCTTCAGGAAG TAGATGGAGAAATTGAAGCTGTCCTGCAAAAGAAAGGCCTGGCGCTGGTGCCGAGGAAGCTCTGTGCCCACTACACTTGGGATGCCAGTG TGCTGCTCCAGGCATGGCCTGCTGTGGACCCGGAGTTCCTGCAGCAGCCTGAGGTTGTCCAGATGGCAGTTCTGATCAACAATAAAGCTT GTGGCAAAATTCCTGTGCCCCAACAAGTTGCCCGGGACCAGGACAAAGTCCACGAATTTGTTCTTCAAAGCGAGCTGGGTGTCAGGCTTT TGCAAGGACGAAGCATCAAGAAGTCCTTCCTTTCCCCGAGAACTGCCCTCATCAACTTCCTGGTGCAAGATTGACAGCCAGGAGGCTGCA GCTACCACGAGGGCCTCTGAGGAACCTCCTTCCAGGCCTGGGATGAGGGGGCGATGTCTGCTGGCCCAGGGGAAGGGAAAAGACAAATGT CTTGACTGTTGACCTCGGTCCTGTGGCAGACTGCAGTCAACAGTGTGCCTCTGTAGTGTGGCCTGGTGCTGGGGTGAAGGTGAGCTGGGC AAAGGAGAAATATGAGCTACTGAGGAGGGGGTTGGACATCCTGCCCCTCACCCCCCACCCACACTGCAGGTAGAGGAGGCCATCTGATCC CATGGGAAGCCATCAGAGACACTGCTGGTGGGAGCAGGAAGGAGCAGTGCCCCTCGAGCAGCCAGGAAGCCTGCGGATCTGGGAAATGGC TCTGCCTTAGGCACTTCTCGGGAATTTGAGGCCAGCCTGAGGAACTGCAGGACTCAGGTGCAATGTGCCAGCCACTTGGAACTGCTAACT GAGCCTCCAGATGGTAGTGAATGGTCTCTTTGCCTTCAGGCTGGATGAGGAAGTCATTTAGGAAATGTTCAAATAACCAATATGTGGAAA TGGACACAGGGATCTTCTGAAGTTGCTTTGAATCAAAAGGCAGGCAGTGCTGGTTCCTCTGCCTGTGTCCCCACCACTCCCCAGCTCTGT CATGCAGGCCTGTCCTCCCCAACCCCAGCTGGATGTGCCTCCCAGGCCTGCTGTGGTTCTGACACACAGGATCCCAGGCAAGGCACCACT TCCTCACATGAATGAGGAGCAGCAAGTCATAACCACTCCCTTGGGTATACAATTTGCTGTGTAGTGAAGTGGAACCAGGCTCAGGCTGCT GGTCCCAACCTCAGAGCCCCACCGCAGCCCAGTAGGGATGCAGCACGCCCCAGAGGGCTCATGTGGGCCCCAGATGGCAATGCCACCATT GTTGATGTGACTCCAGAGCCAGTTATTAGGAAGAGCAAGCTCACCACAGAGGAGTGGAACTGAGGCCCCCCAGATGTTGCCTCCGGTGTC CAAGCCACAGCGGTCTGGCTGTTGGGAAGATGGCCAGGAATGGACTCATACCATTGGCACATTAGGCTAATCCTGGTTTTATGTGAAGTC AGCAATTAAGTGTTCCCACTAGAACTGACCTAAGCCACTGATTAATATTTAATGAGGGAAGGTAGGGGAGAATCTAGCCATTTTATAATG CCAGAAATCTATATATGTTATCTGATGCCATTTTTCTGAAGTAGCCTCACATGTGGTCCCCCTGCAGTTCAGCAGTTAACAGATGACTTT TTTAGTGTAATAAAATGTTTATCATCTATGACTTCAGGACATATGTGTGATCCTGGAATACACCATATTCCAATTTCAGAGTTAATTACA AACAGATTGAGGTATTCCATCATCATCGGAAGCATTGGCTGTGTGTCTGACTCCACATGGAATGCTATAAAGTGGGATACATGTGGTTCT TCTTGTTCCAGAACTTACAGTCCATGGTAGACAACACTGATACAGGCAAACTAGCAACAGCAATTAAGTCACTGGTTCTCAGACTTAATA CTCTGCCTGGTCCTCATGCCCAGATATTCCAATTTAATTGGTCCATGGTGTGGCTTGAACACCAGGAATCTTTAAAACTCCACAAGTGAT TCTAATGGGCAGCAAAGTTTGAGAATCACTGGACACATTGATGCACTTGAGCCATCATTTCTATCTAGTTCTTCCTCTTCCTAATCTTCA GGTTAGCGGGGATAAGTTTGGTCCAGGACCAAGAGTTGGACCAAAAGGGAAGACAGGGGCCAGAAGTCTAGAGTGCTAGAGCCGACTTGA >In-frame_ENST00000469075_ENST00000415258_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(amino acids)=260AA_start in transcript=11_stop in transcript=793 MKPRPAGFVDNKLKQRVIQYLTSNKCGKYVDIGVLASDLQRVYSIDYGRRKRNAFRIQVEKVFSIISSEKELKNLTELEDEHLAKRARQG EEDNEYTESYSDDDSSMEDYPDPQDSKDSSLLESDMKRKGKLKNKGSKRKKEDLQEVDGEIEAVLQKKGLALVPRKLCAHYTWDASVLLQ -------------------------------------------------------------- >In-frame_ENST00000469075_ENST00000414984_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(transcript)=873nt_BP=486nt AGACCGACGCGATGAAGCCCAGACCTGCAGGGTTCGTGGATAATAAACTCAAGCAGCGAGTCATCCAGTACCTTACCAGTAACAAATGTG GCAAATATGTGGACATTGGAGTCTTAGCGTCTGATTTACAAAGAGTGTACAGTATAGACTATGGTCGAAGAAAAAGAAATGCTTTTAGGA TTCAGGTAGAAAAAGTATTTAGCATAATTAGTAGTGAGAAGGAACTTAAGAATTTAACAGAATTAGAAGATGAACATTTGGCAAAAAGGG CAAGACAAGGTGAAGAGGATAATGAGTATACTGAAAGCTATTCTGATGATGATTCAAGTATGGAAGACTACCCAGATCCACAGGATTCAA AAGATTCTTCTCTTTTGGAGAGTGATATGAAACGGAAAGGCAAGCTAAAGAATAAAGGAAGCAAAAGGAAGAAAGAAGATCTTCAGGAAG TAGATGGAGAAATTGAAGCTGTCCTGCAAAAGAAAGGCCTGGCGCTGGTGCCGAGGAAGCTCTGTGCCCACTACACTTGGGATGCCAGTG TGCTGCTCCAGGCATGGCCTGCTGTGGACCCGGAGTTCCTGCAGCAGCCTGAGGTTGTCCAGATGGCAGTTCTGATCAACAATAAAGCTT GTGGCAAAATTCCTGTGCCCCAACAAGTTGCCCGGGACCAGGACAAAGTCCACGAATTTGTTCTTCAAAGCGAGCTGGGTGTCAGGCTTT TGCAAGGACGAAGCATCAAGAAGTCCTTCCTTTCCCCGAGAACTGCCCTCATCAACTTCCTGGTGCAAGATTGACAGCCAGGAGGCTGCA >In-frame_ENST00000469075_ENST00000414984_TCGA-BL-A0C8-01A_NVL_chr1_224492736_-_LARS2_chr3_45583321_length(amino acids)=260AA_start in transcript=11_stop in transcript=793 MKPRPAGFVDNKLKQRVIQYLTSNKCGKYVDIGVLASDLQRVYSIDYGRRKRNAFRIQVEKVFSIISSEKELKNLTELEDEHLAKRARQG EEDNEYTESYSDDDSSMEDYPDPQDSKDSSLLESDMKRKGKLKNKGSKRKKEDLQEVDGEIEAVLQKKGLALVPRKLCAHYTWDASVLLQ -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for NVL-LARS2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000281701 | - | 7 | 23 | 1_220 | 249.33333333333334 | 857.0 | RPL5 |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000340871 | - | 4 | 21 | 1_220 | 33.333333333333336 | 668.0 | RPL5 |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000391875 | - | 6 | 22 | 1_220 | 143.33333333333334 | 751.0 | RPL5 |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000469075 | - | 6 | 22 | 1_220 | 158.33333333333334 | 766.0 | RPL5 |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000281701 | - | 7 | 23 | 267_474 | 249.33333333333334 | 857.0 | WDR74 |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000340871 | - | 4 | 21 | 267_474 | 33.333333333333336 | 668.0 | WDR74 |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000391875 | - | 6 | 22 | 267_474 | 143.33333333333334 | 751.0 | WDR74 |
Hgene | NVL | chr1:224492736 | chr3:45583321 | ENST00000469075 | - | 6 | 22 | 267_474 | 158.33333333333334 | 766.0 | WDR74 |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for NVL-LARS2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for NVL-LARS2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | LARS2 | C0685838 | Gonadal dysgenesis XX type deafness | 10 | CLINGEN;GENOMICS_ENGLAND;ORPHANET |
Tgene | LARS2 | C3809105 | PERRAULT SYNDROME 4 | 3 | GENOMICS_ENGLAND;UNIPROT |
Tgene | LARS2 | C0005586 | Bipolar Disorder | 1 | PSYGENET |
Tgene | LARS2 | C0036341 | Schizophrenia | 1 | PSYGENET |
Tgene | LARS2 | C4310761 | HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA | 1 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |